These success, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the notion of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Issues. Disclaimer: The above is really https://luisc814ecw3.fare-blog.com/profile